Medications

Biogen pulls controversial Alzheimer's drug Aduhelm

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.

Medications

US makes new Alzheimer's drug more widely accessible

The US drug regulator gave full approval to a new Alzheimer's medicine on Thursday, a move that makes it more widely available to the public through government-run health insurance for the elderly.

Medical research

Researchers developing eyedrops to treat cataracts

Many years ago, I began my Ph.D. with the firm resolve of finding a cure for cataracts—not in several years or decades, but within the duration of my Ph.D. Such was my enthusiasm and naivety. Decades later, though, that ...

page 2 from 4